Kewaunee Scientific Q1 net earnings $2.47M vs loss of $0.75M YoY; EPS $0.86 vs ($0.27)

KEWAUNEE SCIENTIFIC CORP /DE/

2024-Q1 EPS reported $0.86 revenue$49,839,000

Net earnings of $2.47M ($0.86 diluted EPS) vs net loss of $0.75M ($0.27 loss) in prior Q1.
Sales of $49.8M, down 0.6% YoY; Domestic sales fell 5.5% to $35.4M, International up 13.9% to $14.4M.
EBITDA rose to $4.3M from $0.28M; backlog was $140.8M vs $174.0M a year ago and $147.9M on April 30.
Domestic segment net income $2.71M vs $0.098M; improved due to stop selling direct, better productivity.
Cash increased to $21.6M from $13.8M (April 30); debt-to-equity 1.05-to-1.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

KEWAUNEE SCIENTIFIC CORP /DE/ reported financial results for first quarter of fiscal year 2024.

Period: first quarter of fiscal year 2024
Result: reported results

Exact text from the filing

On August 31, 2023, Kewaunee Scientific Corporation issued a press release announcing its financial results for the first quarter of fiscal year 2024.

View on SEC.gov

309 earnings releases filed in the last 30 days. Browse all earnings releases →

KEWAUNEE SCIENTIFIC CORP /DE/ filing history →

Source: SEC EDGAR

accession 0000055529-23-000017

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.